Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

China Longitudinal Aging and Cognitive Impairment Study

Authors not listed

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2021

Abstract

This is a multi-center longitudinal study that consists of five cohorts: cognitive normal aging (CN), Subjective cognitive impairment (SCI), mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular cognitive impairment (VCI). The goals of this study are as follow: 1.To establish longitudinal cohort study database containing comprehensive epidemiological data, neuropsychological test data, laboratory parameters, image data and biological samples. 2. To determine the risk factors of AD and other dementias. 3. To explore the conversion rates from CN to SCI, MCI or AD and the risk factors as well as biomarkers for the progression from CN to SCI, MCI or AD. 4. To explore and validate blood, CSF, urine, imaging and other biomarkers for the early detection and progression of AD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Anonymous. (2021). China Longitudinal Aging and Cognitive Impairment Study. <em>Second Affiliated Hospital, Zhejiang University, School of Medicine</em>. https://clinicaltrials.gov/study/NCT05468905
Vancouver
Anonymous. China Longitudinal Aging and Cognitive Impairment Study. Second Affiliated Hospital, Zhejiang University, School of Medicine. 2021.
BibTeX
@misc{anon2021ChinaL, title = {China Longitudinal Aging and Cognitive Impairment Study}, author = {Anonymous}, journal = {Second Affiliated Hospital, Zhejiang University, School of Medicine}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings